The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide

June Guo1, Danna M Breen1, Troy J Pereira2

  • 1Department of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada.

Atherosclerosis
|May 15, 2015
PubMed

Insights

Insulin

Area of Science:

  • Vascular biology
  • Endocrinology
  • Cardiovascular research

Background:

  • Insulin exhibits dual effects on vascular cells in vitro: mitogenic on smooth muscle cells and protective on endothelial cells.
  • Insulin stimulates nitric oxide (NO) production and endothelial nitric oxide synthase (eNOS) expression, crucial for vascular health.
  • Previous in vivo studies demonstrated insulin's ability to reduce neointimal growth and enhance re-endothelialization after arterial injury.

Purpose of the Study:

  • To investigate the role of nitric oxide synthase (NOS), specifically eNOS, in mediating insulin's vasculoprotective effects in vivo.
  • To determine if the beneficial effects of insulin on neointimal formation and re-endothelialization are dependent on NOS activity.

Main Methods:

  • Rats received insulin implants with or without the NOS inhibitor l-NAME before arterial balloon injury.
  • Insulin's effects on neointimal area, cell migration, and re-endothelialization were assessed.
  • Wild-type and eNOS knockout mice were treated with insulin to evaluate neointimal formation after femoral artery injury.

Main Results:

  • Insulin significantly reduced neointimal area and cell migration while increasing re-endothelialization in rats.
  • Co-administration of l-NAME abolished all beneficial effects of insulin, indicating a critical role for NOS.
  • Insulin increased eNOS phosphorylation and improved endothelial-dependent vasorelaxation.
  • Insulin's protective effect against neointimal formation was observed in wild-type mice but absent in eNOS knockout mice.

Conclusions:

  • The vasculoprotective effects of insulin following arterial injury are critically dependent on the endothelial nitric oxide synthase (eNOS) pathway.
  • Insulin promotes vascular healing through an eNOS-dependent mechanism, highlighting its therapeutic potential in cardiovascular diseases.